Tokgozoglu, L. Et Al. 2023. Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers. European heart journal , vol.44, no.25 , 2292-2304.

Tokgozoglu, L., Morrow, D. A., & Nicholls, S. J., (2023). Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers. European heart journal , vol.44, no.25, 2292-2304.

Tokgozoglu, SADBERK, David A. Morrow, And Stephen J. Nicholls. "Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers," European heart journal , vol.44, no.25, 2292-2304, 2023

Tokgozoglu, SADBERK L. Et Al. "Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers." European heart journal , vol.44, no.25, pp.2292-2304, 2023

Tokgozoglu, L. Morrow, D. A. And Nicholls, S. J. (2023) . "Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers." European heart journal , vol.44, no.25, pp.2292-2304.

@article{article, author={SADBERK LALE TOKGÖZOĞLU Et Al. }, title={Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers}, journal={European heart journal}, year=2023, pages={2292-2304} }